Johnson & Johnson (NYSE:JNJ)

Add to Watch List

Set Alert

86.36 Data as of Jun 18	+0.73 / +0.85% Today’s Change	65.82 Today\|\|\|52-Week Range 89.99	+23.20% Year-to-Date

86.36

Data as of Jun 18

+0.73 / +0.85%

Today’s Change

65.82

Today|||52-Week Range

89.99

+23.20%

Year-to-Date

Latest JNJ News | Press Releases

The Top 3 Medical Uses of Botox Jun 18 / MotleyFool.com	Defensive Names Still Catching Bids Jun 12 / TheStreet.com
The FDA Might Pull This Drug From the Market (and Why It Doesn't Matter) Jun 18 / MotleyFool.com	Undervalued Teva Must Enter New Markets Jun 12 / MotleyFool.com
Should You Buy Stocks Discarded By Warren Buffett ? Jun 18 / MotleyFool.com	2 More Good Reasons to Buy Celgene Jun 12 / MotleyFool.com
Old CEO, New Prospects Jun 18 / MotleyFool.com	Inside HCV: An Interview with Janssen Jun 12 / MotleyFool.com
Johnson & Johnson Gets Key Cancer Drug With Aragon Buy Jun 18 / TheStreet.com	Some Top Funds Are Dumping Bonds Jun 12 / TheStreet.com
J&J to Buy Aragon for $1 Billion - Analyst Blog Jun 18 / Zacks.com	New Data Improves Sales Outlook For Celgene's Apremilast Jun 12 / TheStreet.com
Buy-Rated Dow Components Slips To Ten Jun 18 / TheStreet.com	Game-Changing Hep C Pill Closer to Approval Jun 11 / MotleyFool.com
Merger Monday: 2 Blue Chips Making Smart Buys Jun 17 / MotleyFool.com	Tme to Buy This Defensive Growth Stock? Jun 11 / MotleyFool.com
Benzinga's M&A Chatter for Monday June 17, 2013 Jun 17 / Benzinga	Tentative Approval for SUPN Candidate - Analyst Blog Jun 11 / Zacks.com
Trade This Defensive High-Yielder for Double-Digit Gains Jun 17 / Street Authority	3 High Dividend Stocks to Consider at Market Dips Jun 11 / MotleyFool.com
Market Wrap for Tuesday, June 17: Stocks Jump to Start Trading Week; Dow Rallies Trip... Jun 17 / Benzinga	5 Companies That Buy Their Innovation Jun 10 / MotleyFool.com
Why Medivation Shares Retreated Jun 17 / MotleyFool.com	Priority Review for Gilead Drug - Analyst Blog Jun 10 / Zacks.com
American Generics Can't Touch This $8 Billion Drug (Yet) Jun 17 / MotleyFool.com	It's Time to Buy Amgen Stock. Here's Why Jun 07 / MotleyFool.com
Johnson & Johnson to Buy Aragon Pharmaceuticals for $650 Million Up Front Jun 17 / MotleyFool.com	Is This GlaxoSmithKline's Next Big Blockbuster? Jun 07 / MotleyFool.com
5 Stocks Raising The Drugs Industry Higher Jun 17 / TheStreet.com	To Protect Yourself Against Falling Markets, Consider Dollar Cost Averaging Jun 07 / MotleyFool.com
J&J Buy of Aragon Deals a Blow To Medivation Jun 17 / TheStreet.com	Take Your Pick: PG vs JNJ Jun 06 / MotleyFool.com
Company News for June 17, 2013 - Corporate Summary Jun 17 / Zacks.com	Pfizer chief looks to joint ventures to bolster drug development Jun 06 / FT.com
UPDATE: Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharma For... Jun 17 / Benzinga	Looking for Winners? The Dow Had None Today Jun 06 / MotleyFool.com
Johnson & Johnson's Gut Feeling About the Future of Medicine Jun 14 / MotleyFool.com	3 Health Care Investment Ideas for June Jun 05 / MotleyFool.com
New Data on UCB's Cimzia - Analyst Blog Jun 14 / Zacks.com	A Dividend Watchlist for the Pullback Jun 05 / MotleyFool.com
1 Huge Opportunity for the Star Stent of the Future Jun 14 / MotleyFool.com	Consumer companys delay ad payments May 30 / FT.com
Lilly Alzheimer's Study Terminated - Analyst Blog Jun 14 / Zacks.com	Microsoft gives Ballmer a reason to dance again May 30 / CNNMoney.com
Is This Healthcare Company a Strong Investment? Jun 13 / MotleyFool.com	Smithfield fails to light up Wall St May 29 / FT.com
5 Big Trades for a Ping-Pong Market Jun 13 / TheStreet.com	Ackman wins, P&G dumps CEO May 24 / CNNMoney.com
Johnson & Johnson (JNJ): Today's Featured Drugs Laggard Jun 12 / TheStreet.com

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.